REFERENCES:
1.
Agus, Allison, Jérémy Denizot,
Jonathan Thévenot, Sébastien Massier, Pierre Sauvanet, Richard Bonnet,
Elisabeth Billard, and Nicolas Barnich. 2016. “90 Western Diet Induces a Shift
in Microbiota Composition Enhancing Susceptibility to Adherent-Invasive E. Coli
Infection and Intestinal Inflammation.” Gastroenterology 150 (4): S23.
https://doi.org/10.1016/s0016-5085(16)30201-3.
2.
Blekhman, Ran, Julia K. Goodrich,
Katherine Huang, Qi Sun, Robert Bukowski, Jordana T. Bell, Timothy D. Spector,
et al. 2015. “Host Genetic Variation Impacts Microbiome Composition across
Human Body Sites.” Genome Biology 16 (1): 191. https://doi.org/10.1186/s13059-015-0759-1.
3.
Bonder, Marc Jan, Alexander
Kurilshikov, Ettje F. Tigchelaar, Zlatan Mujagic, Floris Imhann, Arnau Vich
Vila, Patrick Deelen, et al. 2016. “The Effect of Host Genetics on the Gut
Microbiome.” Nature Genetics 48 (11): 1407–12. https://doi.org/10.1038/ng.3663.
4.
Brown, Andrew J., Susan M.
Goldsworthy, Ashley A. Barnes, Michelle M. Eilert, Lili Tcheang, Dion Daniels,
Alison I. Muir, et al. 2003. “The Orphan G Protein-Coupled Receptors GPR41 and
GPR43 Are Activated by Propionate and Other Short Chain Carboxylic Acids.” The
Journal of Biological Chemistry. 278 (13): 11312–19.
https://doi.org/10.1074/jbc.M211609200.
5.
Duboc, Henri, Sylvie Rajca,
Dominique Rainteau, David Benarous, Marie-Anne Maubert, Elodie Quervain,
Ginette Thomas, et al. 2013. “Connecting Dysbiosis, Bile-Acid Dysmetabolism and
Gut Inflammation in Inflammatory Bowel Diseases.” Gut 62 (4): 531–39. https://doi.org/10.1136/gutjnl-2012-302578.
6.
Fiorucci, Stefano, and Eleonora
Distrutti. 2015. “Bile Acid-Activated Receptors, Intestinal Microbiota, and the
Treatment of Metabolic Disorders.” Trends in Molecular Medicine 21 (11):
702–14. https://doi.org/10.1016/j.molmed.2015.09.001.
7.
Fritsche, Kevin L. 2015. “The
Science of Fatty Acids and Inflammation.” Advances in Nutrition (Bethesda, Md.)
6 (3): 293S – 301S. https://doi.org/10.3945/an.114.006940.
8.
Gilbert, Jack A., Robert A. Quinn,
Justine Debelius, Zhenjiang Z. Xu, James Morton, Neha Garg, Janet K. Jansson,
Pieter C. Dorrestein, and Rob Knight. 2016. “Microbiome-Wide Association
Studies Link Dynamic Microbial Consortia to Disease.” Nature 535 (7610):
94–103. https://doi.org/10.1038/nature18850.
9.
Goodrich, Julia K., Emily R.
Davenport, Michelle Beaumont, Matthew A. Jackson, Rob Knight, Carole Ober, Tim
D. Spector, Jordana T. Bell, Andrew G. Clark, and Ruth E. Ley. 2016. “Genetic
Determinants of the Gut Microbiome in UK Twins.” Cell Host & Microbe 19
(5): 731–43. https://doi.org/10.1016/j.chom.2016.04.017.
10.
Kawai, Taro, and Shizuo Akira. 2010.
“The Role of Pattern-Recognition Receptors in Innate Immunity: Update on
Toll-like Receptors.” Nature Immunology 11 (5): 373–84.
https://doi.org/10.1038/ni.1863.
11.
Kimura, Ikuo, Kentaro Ozawa, Daisuke
Inoue, Takeshi Imamura, Kumi Kimura, Takeshi Maeda, Kazuya Terasawa, et al.
2013. “The Gut Microbiota Suppresses Insulin-Mediated Fat Accumulation via the
Short-Chain Fatty Acid Receptor GPR43.” Nature Communications 4 (1): 1829.
https://doi.org/10.1038/ncomms2852.
12.
Koh, Ara, Filipe De Vadder, Petia
Kovatcheva-Datchary, and Fredrik Bäckhed. 2016. “From Dietary Fiber to Host
Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites.” Cell 165
(6): 1332–45. https://doi.org/10.1016/j.cell.2016.05.041.
13.
Lagier, Jean-Christophe, Perrine
Hugon, Saber Khelaifia, Pierre-Edouard Fournier, Bernard La Scola, and Didier
Raoult. 2015. “The Rebirth of Culture in Microbiology through the Example of
Culturomics to Study Human Gut Microbiota.” Clinical Microbiology Reviews 28
(1): 237–64. https://doi.org/10.1128/cmr.00014-14.
14.
Ma, Bin, and Michael O. Hottiger.
2016. “Crosstalk between Wnt/β-Catenin and NF-κB Signaling Pathway during
Inflammation.” Frontiers in Immunology 7 (September):378.
https://doi.org/10.3389/fimmu.2016.00378.
15.
Norman, Jason M., Scott A. Handley,
and Herbert W. Virgin. 2014. “Kingdom-Agnostic Metagenomics and the Importance
of Complete Characterization of Enteric Microbial Communities.” Gastroenterology 146 (6): 1459–69.
https://doi.org/10.1053/j.gastro.2014.02.001.
16.
Overton, Hilary A., Adam J. Babbs,
Sheila M. Doel, Matthew C. T. Fyfe, Lisa S. Gardner, Graeme Griffin, Helen C.
Jackson, et al. 2006. “Deorphanization of a G Protein-Coupled Receptor for
Oleoylethanolamide and Its Use in the Discovery of Small-Molecule Hypophagic
Agents.” Cell Metabolism 3 (3): 167–75.
https://doi.org/10.1016/j.cmet.2006.02.004.
17.
Pekow, J., and S. B. Hanauer. 2017.
“The Rise of Microbiota Therapies in Inflammatory Bowel Disease.” Current
Opinion in Gastroenterology 33 (1): 20–26.
18.
Poul, Le. 2003. “Functional
Expression of Human Receptors for Short-Chain Fatty Acids and Their Role in
Glucagon-like Peptide-1 Secretion.” Diabetes 52 (5): 1172–79.
19.
Qin, Junjie, Ruiqiang Li, Jeroen
Raes, Manimozhiyan Arumugam, Kristoffer Solvsten Burgdorf, Chaysavanh
Manichanh, Trine Nielsen, et al. 2010. “A Human Gut Microbial Gene Catalogue
Established by Metagenomic Sequencing.” Nature 464 (7285): 59–65. https://doi.org/10.1038/nature08821.
20.
Ríos-Covián, D. 2016. “Short-Chain
Fatty Acids and Their Link with Diet, Microbiota, and Host Health.” Frontiers
in Microbiology 7.
21.
Ríos-Covián, David, Patricia
Ruas-Madiedo, Abelardo Margolles, Miguel Gueimonde, Clara G. de Los
Reyes-Gavilán, and Nuria Salazar. 2016. “Intestinal Short Chain Fatty Acids and
Their Link with Diet and Human Health.” Frontiers in Microbiology 7 (February):185.
https://doi.org/10.3389/fmicb.2016.00185.
22.
Rooks, M. G., and W. S. Garrett.
2016. “Gut Microbiota, Metabolites, and Host Immunity.” Nature Reviews
Immunology 16 (6): 341–52.
23.
Schilderink, R., C. Verseijden, and
W. J. De Jonge. 2013. “Dietary SCFAs and Immune Modulation by the Gut
Microbiota: Ready for Therapeutic Interventions?” Frontiers in Immunology 4.
24.
Sender, Ron, Shai Fuchs, and Ron
Milo. 2016. “Revised Estimates for the Number of Human and Bacteria Cells in
the Body.” PLoS Biology 14 (8): e1002533.
https://doi.org/10.1371/journal.pbio.1002533.
25.
Stilling, Roman M., Marcel van de
Wouw, Gerard Clarke, Catherine Stanton, Timothy G. Dinan, and John F. Cryan.
2016. “The Neuropharmacology of Butyrate: The Bread and Butter of the
Microbiota-Gut-Brain Axis?” Neurochemistry International 99 (October):110–32.
https://doi.org/10.1016/j.neuint.2016.06.011.
26.
Tan, Jian, Craig McKenzie, Peter J.
Vuillermin, Gera Goverse, Carola G. Vinuesa, Reina E. Mebius, Laurence Macia,
and Charles R. Mackay. 2016. “Dietary Fiber and Bacterial SCFA Enhance Oral
Tolerance and Protect against Food Allergy through Diverse Cellular Pathways.”
Cell Reports 15 (12): 2809–24. https://doi.org/10.1016/j.celrep.2016.05.047.
27.
Vaure, C., and Y. Liu. 2011. “A
Comprehensive Review of Toll-like Receptor Signaling Pathways.” Molecular
Immunology 48:1853–67.
28.
Wang, J. 2016. “Genome-Wide
Association Analysis Identifies Variation in Vitamin D Receptor and Other Host
Factors Influencing the Gut Microbiome.” Nature Genetics 48 (12): 1396–1406.
29.
Wang, Jun, Louise B. Thingholm,
Jurgita Skiecevičienė, Philipp Rausch, Martin Kummen, Johannes R. Hov, Frauke
Degenhardt, et al. 2016. “Genome-Wide Association Analysis Identifies Variation
in Vitamin D Receptor and Other Host Factors Influencing the Gut Microbiota.”
Nature Genetics 48 (11): 1396–1406. https://doi.org/10.1038/ng.3695.
30.
Wang, K., and Z. Chen. 2008.
“PXR-Mediated Detoxification and Glucose Metabolism in the Gut.”
Pharmacological Reviews 60 (4): 374–93.
31.
Yarovinsky, Felix, Dekai Zhang, John
F. Andersen, Gerard L. Bannenberg, Charles N. Serhan, Matthew S. Hayden, Sara
Hieny, et al. 2005. “TLR11 Activation of Dendritic Cells by a Protozoan
Profilin-like Protein.” Science (New York, N.Y.) 308 (5728): 1626–29.
https://doi.org/10.1126/science.1109893.
32.
Yatsunenko, Tanya, Federico E. Rey,
Mark J. Manary, Indi Trehan, Maria Gloria Dominguez-Bello, Monica Contreras,
Magda Magris, et al. 2012. “Human Gut Microbiome Viewed across Age and
Geography.” Nature 486 (7402): 222–27. https://doi.org/10.1038/nature11053.
33.
Zeng, M. Y. 2012.
“Microbiota-Induced Innate Immune Signaling through MyD88 Mediates Airway
Hyperresponsiveness and Inflammation.” The Journal of Immunology 188 (7):
3220–28.
34.
Rumyantsev, K. A., Polyakova, V. V.,
Sorokina, I. V., Feoktistova, P. S., Khatkov, I. E., Bodunova, N. A., &
Zhukova, L. G. (2024). The Gut Microbiota Impacts Gastrointestinal Cancers
through Obesity, Diabetes, and Chronic Inflammation. Life, 14(10), 1219.
https://doi.org/10.3390/life14101219
35.
Acevedo-Román, A., Pagán-Zayas, N.,
Velázquez-Rivera, L. I., Torres-Ventura, A. C., & Godoy-Vitorino, F.
(2024). Insights into Gut Dysbiosis: Inflammatory Diseases, Obesity, and
Restoration Approaches. International Journal of Molecular Sciences, 25(17),
9715. https://doi.org/10.3390/ijms25179715
36.
Kastl, A.J., Jr.; Terry, N.A.; Wu,
G.D.; Albenberg, L.G. The Structure and Function of the Human Small Intestinal
Microbiota: Current Understanding and Future Directions. Cell Mol.
Gastroenterol. Hepatol. 2020, 9, 33–45.